Accelerating the development of new cancer therapies; Ketil Widerberg, General Manager, Oslo Cancer Cluster




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Accelerating the development of new cancer therapies; Ketil Widerberg, General Manager, Oslo Cancer Cluster
Released on: June 30, 2014. © PTV
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Four out of ten people will be diagnosed with cancer during their life and it is crucial to develop new diagnostics and medication.
  • Summary
  • Transcript
  • Participants
  • Company
Four out of ten people will be diagnosed with cancer during their life and it is crucial to develop new diagnostics and medication. Oslo Cancer Cluster is an oncology research and industry cluster dedicated to accelerating the development of new cancer diagnostics and medicines. Ketil Widerberg, General Manager, Oslo Cancer Cluster explains to Fintan Walton how their core expertise in the field of Immuno-Oncology makes them well positioned to contribute in this field and how several research projects and ongoing clinical trials will contribute to an exciting pipeline of novel cancer immunotherapies.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Ketil Widerberg
Oslo Cancer Cluster
Oslo Cancer Cluster